Online citations, reference lists, and bibliographies.

Neuroinflammation And Neuromodulation In Neurological Diseases

M A Robinson-Agramonte, Carlos-Alberto Gonçalves, Roberto Farina de Almeida, Alina González Quevedo, Sandra Chow, Luis Velázquez Pérez, Amado Díaz de la Fé, Patrícia Sesterheim, Diogo Gomes de Souza
Published 2019 · Psychology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Neuroimmunology is a relatively young science. This discipline has emerged today from the research field as a mature and fully developed innovative research area that integrates not only pure topics of neuroimmunology, but also expands on wider fields such as neuroplasticity, neuronal reserve and neuromodulation in association with clinical events, amongst which behavioral disorders stand out. The Cuban School of Neuroimmunology—a recent meeting that took place in Havana, Cuba—focused on topics based on the molecular mechanisms of neuroinflammation in neurological disorders involving behavioral manifestations, such as multiple sclerosis (MS), autism, cerebellar ataxias, Alzheimer´s disease and stroke among others, as well as on the use of new interventional technologies in neurology. Professor Luis Velazquez, from the Cuban Academy of Sciences, dictated an interesting lecture on Spinocerebellar ataxias, a genetic disorder where recent hypotheses related to the influence of neuroinflammation as a neurobiological factor influencing the progression of this disease have emerged. At the same time, the use of new interventional technologies in neurology was discussed, including those referring to novel disease modifying therapies in the course of MS and the use of transcranial magnetic stimulation in several neurological diseases, the latter reinforcing how interventional strategies in the form of non-invasive bran stimulation can contribute to physical rehabilitation in neurology. This paper summarizes the highlights of the most relevant topics presented during the First Cuban School of Neuroimmunology, organized by the Cuban Network of Neuroimmunology, held in June 2019.
This paper references
Neuromodulatory e ff ects of guanine - based purines in health and disease
C. I. Tasca (2018)
10.1177/0961203318804899
Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous
E Noris-García (2018)
10.1007/978-1-61779-452-0_3
Heterogeneity of astrocytic form and function.
Nancy Ann Oberheim (2012)
10.1080/14740338.2017.1388371
Drugs approved for the treatment of multiple sclerosis: review of their safety profile
Fabiana Auricchio (2017)
10.3390/bs6040029
Peripheral Inflammatory Markers Contributing to Comorbidities in Autism
Martha Cecilia Inga Jácome (2016)
Disease Modification: For-professionals/clinical-care/managing-ms/ disease-modification. Accessed 10/19/18; owens gm
(2013)
10.1002/mds.26969
Prodromal spinocerebellar ataxia type 2: Prospects for early interventions and ethical challenges
Luis C. Velázquez-Pérez (2017)
Disease Modification : For - professionals / clinical - care / managing - ms / disease - modification . Accessed 10 / 19 / 18 ; owens gm . Am
R. Rodr í guez-Labrada (2013)
10.1038/nrneurol.2015.144
Immune interventions in stroke
Ying Fu (2015)
10.1016/j.pharmthera.2007.07.004
Proposal of a guanine-based purinergic system in the mammalian central nervous system.
André Prato Schmidt (2007)
10.1161/CIRCRESAHA.116.308427
Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke
Xiaoming Hu (2017)
10.1016/j.semcdb.2019.04.002
The astrocyte biochemistry.
Débora Guerini Souza (2019)
10.1007/s12640-012-9348-1
Neuroinflammation, Neurodegeneration, and Depression
Laura L. Hurley (2012)
10.1186/1742-2094-8-128
Lipopolysaccharide modulates astrocytic S100B secretion: a study in cerebrospinal fluid and astrocyte cultures from rats
Maria Cristina Guerra (2010)
10.1007/978-3-319-16321-5_9
Understanding on Neuroimmunology in Autism Spectrum Disorder
Amaicha Mara Depino (2015)
10.1007/s11481-013-9480-6
Immune Players in the CNS: The Astrocyte
Cathy Joanna Jensen (2013)
10.3389/fneur.2017.00472
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
Luis C. Velázquez-Pérez (2017)
10.1186/s12974-014-0158-7
Calcineurin and glial signaling: neuroinflammation and beyond
Jennifer L Furman (2014)
10.3389/fncel.2018.00376
Neuromodulatory Effects of Guanine-Based Purines in Health and Disease
Carla Inês Tasca (2018)
10.1515/revneuro-2017-0092
Gliotransmitters and cytokines in the control of blood-brain barrier permeability
Elena Osipova (2018)
10.1016/S1474-4422(11)70066-7
Stroke and the immune system: from pathophysiology to new therapeutic strategies
Richard Macrez (2011)
10.1016/j.ejmech.2018.11.014
Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia.
Yin Luo (2019)
10.1016/j.neulet.2013.12.030
Heterogeneity of reactive astrocytes
Mark A. Anderson (2014)
Disease Modification : For - professionals / clinical - care / managing - ms / disease - modification . Accessed 10 / 19 / 18 ; owens gm . Am
R. Rodr í guez-Labrada (2013)
10.1016/j.tins.2015.04.003
Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
Zhihui Yang (2015)
10.1161/CIRCRESAHA.116.308413
Global Burden of Stroke.
Valery L Feigin (2017)
10.1016/S1474-4422(14)70027-4
Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study
Luis C. Velázquez-Pérez (2014)



Semantic Scholar Logo Some data provided by SemanticScholar